Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Perspectives for the chemotherapy of respiratory syncytial virus (RSV) infections — De Clercq Erik (1996) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Perspectives for the chemotherapy of respiratory syncytial virus (RSV) infections
Shared by
De Clercq Erik
KU Leuven
Perspectives for the chemotherapy of respiratory syncytial virus (RSV) infections
Article
1996
en
Authors
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2015
Chemotherapy of respiratory syncytial virus infections: the final breakthrough
De Clercq Erik
Article
1999
Perspectives for the treatment of hepatitis B virus infections
De Clercq Erik
Letter
2025
Assessing monoclonal antibodies for respiratory virus infections
Sir Nicholas White
,
William HK Schilling
,
Podjanee Jittamala
,
Phrutsamon Wongnak
,
James A Watson
Article
1994
Chemotherapy of varicella zoster virus infections
Robert Snoeck
,
Graciela Andreï
,
De Clercq Erik
Article
1987
Inhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitro
Fuyuhiko Kawana
,
Shirô Shigeta
,
Mitsuaki Hosoya
,
Hitoshi Suzuki
,
De Clercq Erik
Discussion(0)
No comments yet. Be the first to comment.